Business
Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call
CELEBRATION, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate and financial results for the fourth quarter and full year 2025 on Monday, March 9, 2026, via a news release after the market close, and will host a conference call/audio webcast at 4:30 p.m. ET that day. A link to the audio webcast will be ac
About this update from Zevra Therapeutics, Inc.
[{"type":"image","alt":"Zevra Therapeutics","displaySize":"","headline":null,"caption":"Zevra Therapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":80,"url":"https://media.zenfs.com/en/globenewswire.com/47aa28c5ce5943ac0fb423dcc40d01c5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/BTrlkcW3K5pHsBf7HqZtVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/47aa28c5ce5943ac0fb423dcc40d01c5","width":300,"height":80}},"lazy":false},{"type":"text","content":"CELEBRATION, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate and financial results for the fourth quarter and full year 2025 on Monday, March 9, 2026, via a news release after the market close, and will host a conference call/audio webcast at 4:30 p.m. ET that day.","length":461,"tagName":"p"},{"type":"text","content":"A link to the audio webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website at investors.zevra.com.","length":169,"tagName":"p"},{"type":"text","content":"To join via telephone, please use the following dial-in information:","length":68,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"(800) 579-2543 (United States)","length":30,"tagName":"p"}]},{"val":[{"type":"text","content":"+1 (785) 424-1789 (International)","length":33,"tagName":"p"}]},{"val":[{"type":"text","content":"Conference ID: ZVRAQ425","length":23,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":86,"olType":false},{"type":"text","content":"A replay of the webcast will be available for 90 days beginning at approximately 5:30 p.m. ET. The replay will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website at investors.zevra.com.","length":247,"tagName":"p"},{"type":"text","content":"About Zevra Therapeutics, Inc.","length":30,"tagName":"p"},{"type":"text","content":"Zevra Therapeutics, Inc. is a purpose-driven, commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases. The company’s commercialization of its lead product, marketed in th...